This company offers contract research services for drug discovery and translational development, specializing in advanced analytical technologies for biomarker discovery, validation, and bioanalysis. They provide comprehensive platforms for developing life-saving therapies and medical devices, including support for cell and gene therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Drug discovery and translational development require comprehensive analytical services to effectively identify and validate biomarkers, as well as conduct bioanalysis. Existing solutions may lack the breadth of services, advanced technologies, and regulatory compliance necessary to accelerate the development of novel therapies and medical devices.
Solution
Axela Bio provides contract research services for drug discovery and translational development, integrating state-of-the-art platforms, innovative methodologies, and regulatory-compliant workflows. The company delivers data-driven solutions, including biomarker discovery, validation, and bioanalysis, to accelerate therapeutic breakthroughs. Axela Bio offers customizable assay services, method development, and tailored consultation to meet the unique needs of biotech and pharmaceutical partners. Their integrated infrastructure leverages advanced instrumentation, automation, and regulatory-compliant workflows to provide robust solutions tailored to novel modalities.
Target Audience
Axela Bio serves biotech companies, global pharmaceutical firms, and academic institutions involved in drug discovery, translational development, and clinical research.
Features
- Ultrasensitive, multiplex immunoassays and microarrays for quantifying proteins and genes across diverse samples
- High-dimensional flow cytometry for immune monitoring, offering customizable immune profiling, cytokine analysis, and cell phenotyping assays
- Spatial genomics, transcriptomics, and proteomics for mapping cell atlases across tissues, including NanoString GeoMX and nCounter analysis
- CLIA-certified testing laboratory
- Capability to quantify any protein or gene across diverse samples
- High-throughput screening and automation for rapid screening of compounds and immune modulators
- Custom assay development, hybridization optimization, and data analysis for microarray services
- Immunoassay services including ELISA, multiplex bead-based assays, and customized immunoassay development
- Capability to perform T cell, B cell, and Natural Killer cell functional assays